中青年宫颈癌患者癌症复发恐惧现状及影响因素的研究-现代医学

中青年宫颈癌患者癌症复发恐惧现状及影响因素的研究

单位：1. 新疆医科大学护理学院, 新疆乌鲁木齐 830054;
2. 新疆医科大学附属肿瘤医院妇科肿瘤放射治疗科一病区, 新疆乌鲁木齐 830054;
3. 成都市第三人民医院肾内科, 四川成都 610014

分类号：R473.73

出版年·卷·期（页码）：2024·52·第一期（115-121）

摘要：

目的：探究中青年宫颈癌患者癌症复发恐惧的现状，并分析其影响因素，为临床针对性管理与干预癌症复发恐惧提供参考依据。方法：采用便利法，抽取2023年2月至5月新疆某三级甲等肿瘤专科医院就诊的228例宫颈癌患者作为研究对象。使用一般资料调查表、癌症复发恐惧量表简表、元认知问卷、安德森症状评估量表进行问卷调查。结果：癌症复发恐惧量表简表(FCRI-SF)得分为(14.52±5.62)分,57.02%的患者存在较高水平的癌症复发恐惧。单因素分析结果显示，不同年龄、文化程度、家庭人均月收入、宫颈癌FIGO分期与患者癌症复发恐惧得分差异有统计学意义(P<0.001)，相关性分析显示癌症复发恐惧与患者症状困扰(r=0.384，P<0.01)、元认知(r=0.662,P<0.01)呈正相关。多元线性回归分析显示，年龄、文化程度、宫颈癌FIGO分期、症状困扰、元认知是癌症复发恐惧的影响因素，共同解释复发恐惧水平总变异的75.5%(P<0.001)。结论：中青年宫颈癌患者癌症复发恐惧情况不容乐观，应重点关注年轻、文化程度低、疾病分期高的患者，并考虑通过症状管理和纠正适应不良的元认知入手制定有针对性的干预措施。

Objective: To explore the current situation of fear of cancer recurrence in young and middle-aged patients with cervical cancer, and to analyze its influencing factors, so as to provide reference for clinical targeted management and intervention of fear of cancer recurrence. Methods: Using the convenience method, 228 patients with cervical cancer who were treated in a tertiary cancer hospital in Xinjiang from February to May 2023 were selected as the research objects. Questionnaires were conducted using the General Information Questionnaire, the Fearof Cancer Recurrence Inventory Short Form(FCRI-SF), the Metacognitions Questionnaire(MCQ-30), the M.D. Anderson Symptom Inventory(MDASI). Results: The FCRI-SF score was(14.52±5.62), and 57.02%of patients had a high level of fear of cancer recurrence. The results of univariate analysis showed that there were statistically significant differences in the scores of fear of cancer recurrence among patients with different age, education level, family per capita monthly income, and FIGO stage of cervical cancer(all P<0.001). Correlation analysis showed that fear of cancer recurrence was positively correlated with symptom distress(r=0.384,P<0.01) and metacognition(r=0.662,P<0.01). Multiple linear regression analysis showed that age, education level, FIGO stage of cervical cancer, symptom distress and metacognition were the influencing factors of fear of cancer recurrence, which jointly explained 75.5%of the total variation of fear of cancer recurrence(P<0.001). Conclusion: The fear of cancer recurrence in young and middle-aged patients with cervical cancer is not optimistic. We should focus on young patients with low education level and high disease stage,and consider formulating targeted interventions through symptom management and correcting the meta-cognition of maladjustment.

参考文献：

[1] 刘宗超，李哲轩，张阳，等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志，2021，7(2)：1-14.
[2] 孟媛，温笑莹，于方媛，等.中国成年女性宫颈癌患病率Meta分析[J].肿瘤预防与治疗，2023，36(2)：96-110.
[3] 谢珊艳，任鹏.宫颈癌发病年轻化的趋势分析与相应对策[J].中医药管理杂志，2018，26(5)：10-12.
[4] 王瑾瑶，张年萍，白志强，等.1993—2017年中国宫颈癌发病率和死亡率长期趋势的年龄—时期—队列模型分析[J].中国全科医学，2022，25(13)：1564-1568.
[5] COHEN P A,JHINGRAN A,OAKNIN A,et al.Cervical cancer[J].Lancet,2019,393(10167):169-182.
[6] 杨茹，田甜，张靖，等.宫颈癌组织KLK4、STAG2的表达及其临床意义[J].东南大学学报(医学版)，2023，42(4)：540-546.
[7] 谢鹏，郭秋芬，张师前.复发性子宫颈癌的综合治疗[J].中国实用妇科与产科杂志，2022，38(5)：499-503.
[8] LEBEL S,OZAKINCI G,HUMPHRIS G,et al.From normal response to clinical problem:definition and clinical features of fear of cancer recurrence[J].Support Care Cancer,2016,24(8):3265-3268.
[9] WELLS A,MATTHEWS G.Modelling cognition in emotional disorder:the S-REF model[J].Behav Res Ther,1996,34(11-12):881-888.
[10] YANG Y,WEN Y,BEDI C,et al.The relationship between cancer patient's fear of recurrence an chemotherapy:a systematic review and meta-analysis[J].J Psychosom Res,2017,98:55-63.
[11] 彭巧华，吕卫国.2022年第1版《NCCN子宫颈癌临床实践指南》解读[J].实用肿瘤杂志，2022，37(3)：205-214.
[12] 方积乾.卫生统计学[M].北京：人民卫生出版社，2012：399-400.
[13] FARDELL J E,JONES G,SMITH A B,et al.Exploring the screening capacity of the fear of cancer recurrence inventory-short form for clinical levels of fear of cancer recurrence[J].Psycho-Oncology,2018,27(2):492-499.
[14] CLEELAND C S,MENDOZA T R,WANG X S,et al.Assessing symptom distress in cancer patients:the M.D.Anderson Symptom Inventory[J].Cancer,2000,89(7):1634-1646.
[15] 王晓玲，贾宁.焦虑障碍的元认知问卷的编制、变式与应用[J].心理技术与应用，2019，7(12)：746-755.
[16] 姚敏，周昔红，夏春芳，等.宫颈癌患者恐惧疾病进展现状及影响因素分析[J].中华护理杂志，2022，57(18)：2232-2239.
[17] 苏思慧，王佳琳，唐萍，等.中国癌症幸存者恐惧疾病进展发生情况及其影响因素meta分析[J].中国公共卫生，2023，39(2)：170-176.
[18] LOUGHAN A R,LANOYE A,ASLANZADEH F J,et al.Fear of cancer recurrence and death anxiety:unaddressed concerns for adult neuro-oncology patients[J].J Clin Psychol Med Settings,2021,28(1):16-30.
[19] 刘明盛，张丹，张勇.宫颈癌患者复发恐惧感与其生存质量及心理状态的相关性分析[J].重庆医学，2019，48(12)：2118-2121.
[20] SUN Y S,CHEN W L,WU W T,et al.The fact of return to work in cervical cancer survivors and the impact of survival rate:an 11-year follow-up study[J].Int J Environ Res Public Health,2021,18(20):10703.
[21] 覃彦珠，江锦芳，刘鑫，等.妇科肿瘤患者恐惧疾病进展现状调查及其影响因素分析[J].广西医学，2019，41(9)：1180-1183.
[22] HANPRASERTPONG J,GEATER A,JIAMSET I,et al.Fear of cancer recurrence and its predictors among cervical cancer survivors[J].J Gynecol Oncol,2017,28(6):e72.
[23] HALL D L,JIMENEZ R B,PEREZ G K,et al.Fear of cancer recurrence:amodel examination of physical symptoms,emotional distress,and health behavior change[J].J Oncol Pract,2019,15(9):e787-e797.
[24] ZHANG X,SUN D,QIN N,et al.Factors correlated with fear of cancer recurrence in cancer survivors:a meta-analysis[J].Cancer Nurs,2022,45(5):406-415.
[25] 程颖，柳菁菁.《中国肿瘤药物治疗相关恶心呕吐防治专家共识(2022年版)》解读[J].临床内科杂志，2023，40(5)：351-353.
[26] BUBIS L D,DAVIS L,MAHAR A,et al.Symptom burden in the first year after cancer diagnosis:an analysis of patient-reported outcomes[J].J Clin Oncol,2018,36(11):1103-1111.
[27] 张榴红，周婷，黄峥，等.妇科肿瘤患者负性情绪和元认知在躯体症状与恐惧疾病进展间的链式中介作用[J].中华行为医学与脑科学杂志，2022，31(11)：1002-1007.
[28] MUTLU H H,BILICAN F I,MUTLU H H,et al.A comparison of metacognitive factors among patients with cancer and the control group[J].Psychooncology,2018,27(4):1277-1283.
[29] 程春燕，崔盼盼，郑美琼.元认知疗法在癌症幸存者中的应用研究进展[J].护理研究，2023，37(5)：883-886.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录